Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance.

Published in:

Obesity (19307381), 2011, v. 19, n. 7, p. 1404, doi. 10.1038/oby.2010.352

By:

• Aronne, Louis J.;
• Finer, Nick;
• Hollander, Priscilla A.;
• England, Richard D.;
• Klioze, Solomon S.;
• Chew, Robert D.;
• Fountaine, Robert J.;
• Powell, Coralie M.;
• Obourn, John D.

Publication type:

Article